» Articles » PMID: 28340043

Very Long-term Outcome Following Transcatheter Ablation of Atrial Fibrillation. Are Results Maintained After 10 Years of Follow Up?

Overview
Journal Europace
Date 2017 Mar 25
PMID 28340043
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Atrial fibrillation (AF) transcatheter ablation is a safe and effective procedure. However, outcome over 10 years of follow-up has never been reported. The aim of this study is to assess outcome, describe predictors of recurrences, and report on quality of life (QoL) the decade after an AF ablation.

Methods And Results: Patients referred for AF ablation in a single high volume centre from June 2004 to June 2006 were enrolled and followed in a prospective fashion by yearly clinical assessment and Holter monitoring. Among 255 patients (42.7% paroxysmal AF, 77% males, after a follow-up of 125 ± 7 months), 132 (52%) were arrhythmia-free including (58, 32% after a single procedure) while 27 (10%) progressed to permanent AF. At multivariate analysis, a greater left atrium antero-posterior diameter (HR 1.05 95% CI 1.02-1.09, P = 0.02) related to arrhythmic recurrences, while no increase in blood pressure (HR 0.06 95% CI 0.02-0.20, P = 0.01), BMI (HR 0.06 95% CI 0.02-0.09, P < 0.001), and fasting glucose (HR 0.58 95% CI 0.36-0.92, P = 0.02) during follow-up were protective for arrhythmic recurrences. Overall QoL improved significantly, significantly related to the absence of recurrences, arrhythmic burden reduction and blood pressure, and BMI control (P < 0.001).

Conclusion: The outcome of AF ablation over more than 10 years is characterized by a low incidence of progression towards permanent AF. Greater LA anteroposterior diameter related to arrhythmic recurrences, while blood pressure, BMI, and fasting blood glucose control emerged as predictors of sinus rhythm maintenance. Eventually, QoL improved significantly over the follow-up.

Citing Articles

Incremental Efficacy for Repeat Ablation Procedures for Catheter Ablation of Atrial Fibrillation: 5-Year Follow-Up.

Sanchez-Somonte P, Kittichamroen N, Gao-Kang J, Azizi Z, Alipour P, Kahykin Y JACC Adv. 2024; 3(9):101200.

PMID: 39247677 PMC: 11380002. DOI: 10.1016/j.jacadv.2024.101200.


Left atrial appendage therapies: a new topic for the Heart Team.

Branzoli S, Guarracini F, Marini M Ann Cardiothorac Surg. 2024; 13(1):88-90.

PMID: 38380142 PMC: 10875203. DOI: 10.21037/acs-2023-afm-10.


[Long-term success after catheter ablation of atrial fibrillation].

Rottner L, Metzner A Herzschrittmacherther Elektrophysiol. 2023; 34(4):286-290.

PMID: 37863850 DOI: 10.1007/s00399-023-00972-1.


Association of Atrial Fibrillation Recurrence with Right Coronary Atherosclerosis and Increased Left Arterial Epicardial Fat Following Catheter Ablation-Results of a Multimodality Study.

Bordi L, Benedek T, Kovacs I, Opincariu D, Marton E, Parajko Z Life (Basel). 2023; 13(9).

PMID: 37763295 PMC: 10533029. DOI: 10.3390/life13091891.


Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal.

Lip G, Proietti M, Potpara T, Mansour M, Savelieva I, Tse H Europace. 2023; 25(9).

PMID: 37622590 PMC: 10451006. DOI: 10.1093/europace/euad226.